Si Shi
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism 20
- Cancer Genomics and Diagnostics 16
- MicroRNA in disease regulation 16
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research 79
- Cancer Immunotherapy and Biomarkers 14
- Cancer Cells and Metastasis 14
- Molecular Biology top 1%
- Epigenetics and DNA Methylation 22
- RNA modifications and cancer 14
- Immunology top 1%
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Si Shi
194 papers receiving 9.8k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 3.7k
- Oncology 3.4k
- Molecular Biology 5.7k
- Immunology 1.6k
- Pulmonary and Respiratory Medicine 2.0k
Countries citing papers authored by Si Shi
This map shows the geographic impact of Si Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si Shi more than expected).
Fields of papers citing papers by Si Shi
This network shows the impact of papers produced by Si Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si Shi. The network helps show where Si Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Si Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 11 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 9 | |
| 10 | 2023 | 1 | |
| 11 | Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectivesbreakdown → | 2022 | 151 |
| 12 | 2022 | 39 | |
| 13 | 2022 | 4 | |
| 14 | 2021 | 13 | |
| 15 | 2020 | 34 | |
| 16 | 2019 | 120 | |
| 17 | 2018 | 116 | |
| 18 | 2017 | 46 | |
| 19 | 2017 | 8 | |
| 20 | 2016 | 76 |
About Si Shi
Si Shi is a scholar working on Oncology, Cancer Research, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 209 papers that have together received 9.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (79 papers), Epigenetics and DNA Methylation (22 papers), Cancer, Hypoxia, and Metabolism (20 papers), Cancer Genomics and Diagnostics (16 papers), MicroRNA in disease regulation (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), RNA modifications and cancer (14 papers) and Cancer Cells and Metastasis (14 papers). The work is most often cited by research in Cancer Research (3.7k citations), Oncology (3.4k citations), Molecular Biology (5.7k citations), Immunology (1.6k citations) and Pulmonary and Respiratory Medicine (2.0k citations). Si Shi has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xianjun Yu, Jin Xu, Chen Liang, Jie Hua, Qingcai Meng, Jiang Liu, Rong Tang, Bo Zhang, Wei Wang and Bo Zhang. Their work appears in journals such as Molecular Cancer, Frontiers in Oncology, Cancer Letters, Journal of Hematology & Oncology and Current Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.